Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing home and hospital care for non-invasive ventilation in motor neurone disease

Official title: Home Initiation and Monitoring of Non-invasive Ventilation (NIV) Versus Hospital-based Care in People with Motor Neurone Disease (MND) : a Randomised Control Trial (RCT) and Qualitative Study

Run by Papworth Hospital NHS Foundation Trust · NCT06844370 · Data updated 2026-11-12

This study is testing whether using non-invasive ventilation at home can help people with Motor Neurone Disease breathe better and live more comfortably compared to getting treatment in the hospital.

More Respiratory Insufficiency trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorPapworth Hospital NHS Foundation Trust
Government
Locations1 site (Cambridge)
StatusRecruiting
StartedMarch 6, 2024
Main results expectedFebruary 2026
Study endsSeptember 2026
Registry record updatedFebruary 25, 2025
Trial IDNCT06844370 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults diagnosed with Motor Neurone Disease who require non-invasive ventilation due to respiratory failure symptoms.

Probably not a fit

Patients with severe co-morbidities or those who cannot manage home NIV due to cognitive impairment or lack of support will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness and safety of home-based non-invasive ventilation (NIV) compared to traditional hospital-based care for patients with Motor Neurone Disease (MND) experiencing respiratory insufficiency. It aims to recruit 60 patients who will be randomly assigned to receive either home NIV setup with telemonitoring or hospital-based treatment. The goal is to determine if home treatment can provide similar benefits in terms of quality of life and survival while being more convenient for patients with increasing disabilities. The study addresses the challenges faced by patients who find frequent hospital visits difficult due to their condition.

Why it matters

Potential benefit: If successful, this study could provide a more convenient and equally effective option for managing respiratory difficulties in patients with MND.

How similar studies have gone: While the approach of home NIV is promising, it is not widely tested in this specific patient population, making this study a novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults with a diagnosis of Motor Neurone Disease confirmed by a neurologist specialising in MND.
* Indications to NIV: daytime pCO2 \>6.0 kPa or/and symptoms of ventilatory failure (e.g. orthopnoea, paroxysmal nocturnal dyspnoea, morning drowsiness) in the presence of significant diaphragmatic weakness confirmed by respiratory muscle tests

Exclusion Criteria:

* Cognitive impairment precluding understanding of the study protocol and valid consent
* Severe co-morbidities (e.g. decompensated heart failure, severe chronic obstructive pulmonary disease (COPD), morbid obesity) causing or contributing to respiratory failure
* Immediate need to start NIV (\<24hrs) and/or acute illness requiring inpatient treatment e.g. intravenous antibiotics for pneumonia (in addition to the need for NIV)
* Lack of a sufficient social/professional network to support NIV application at home
* Not wishing to accept home NIV

Where it's running

  • Royal Paworth Hospital
    Cambridge, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.